Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

International Stem Cell (ISCO) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for International Stem Cell (ISCO) over the last 17 years, with Q3 2025 value amounting to 1.73.

  • International Stem Cell's Asset Utilization Ratio rose 956.03% to 1.73 in Q3 2025 from the same period last year, while for Sep 2025 it was 1.73, marking a year-over-year increase of 956.03%. This contributed to the annual value of 1.72 for FY2024, which is 1621.92% up from last year.
  • According to the latest figures from Q3 2025, International Stem Cell's Asset Utilization Ratio is 1.73, which was up 956.03% from 1.65 recorded in Q2 2025.
  • In the past 5 years, International Stem Cell's Asset Utilization Ratio ranged from a high of 1.76 in Q4 2024 and a low of 1.11 during Q2 2021
  • For the 5-year period, International Stem Cell's Asset Utilization Ratio averaged around 1.48, with its median value being 1.46 (2024).
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first tumbled by 2020.05% in 2021, then surged by 2774.48% in 2022.
  • International Stem Cell's Asset Utilization Ratio (Quarter) stood at 1.45 in 2021, then grew by 10.7% to 1.61 in 2022, then decreased by 12.15% to 1.41 in 2023, then increased by 24.28% to 1.76 in 2024, then fell by 1.18% to 1.73 in 2025.
  • Its last three reported values are 1.73 in Q3 2025, 1.65 for Q2 2025, and 1.68 during Q1 2025.